Analyst ratings often influence investor sentiment and can impact stock prices. In this case, Alpine Immune Sciences has received 8 bullish ratings and no bearish or indifferent ratings in the last quarter, which is a positive signal. Furthermore, the increase in the average 12-month price target suggests that analysts have a positive outlook on the company's future performance.